Botanical species · safety record
Asclepias tuberosa
The EFSA Compendium of Botanicals holds 6 constituent measurements for Asclepias tuberosa. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.
Accepted name in source: Asclepias tuberosa L.
Regulatory presence
Health Canada's Licensed Natural Health Products Database holds 30 licensed products naming Asclepias tuberosa as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.
Extract types on licence
Source material stated
What the records describe
Constituents measured
- Pregnane derivatives3
- Calotropin1
- Cardenolide glycosides1
- Cardenolides1
Plant parts
- Roots and other underground parts5
- Aerial part of plants1
Preparations
- Solvent extraction6
Recorded constituents
What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.
| Substance | Plant part | Preparation | Concentration | Analytical method | Source |
|---|---|---|---|---|---|
| Pregnane derivatives | Roots and other underground parts | Solvent extraction | — | Nuclear Magnetic Resonance (NMR) | Resolve DOI |
| Pregnane derivatives | Aerial part of plants | Solvent extraction | — | Nuclear Magnetic Resonance (NMR) | Resolve DOI |
| Calotropin | Roots and other underground parts | Solvent extraction | — | Nuclear Magnetic Resonance (NMR) | No resolvable identifier |
| Cardenolide glycosides | Roots and other underground parts | Solvent extraction | — | Nuclear Magnetic Resonance (NMR) | No resolvable identifier |
| Cardenolides | Roots and other underground parts | Solvent extraction | — | Nuclear Magnetic Resonance (NMR) | No resolvable identifier |
| Pregnane derivatives | Roots and other underground parts | Solvent extraction | — | Nuclear Magnetic Resonance (NMR) | No resolvable identifier |
Cited sources
The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.
- Abe, F., Yamauchi, T. An androstane bioside and 3 '-thiazolidinone derivatives of doubly-linked cardenolide glycosides from the roots of Asclepias tuberosa . Chemical & pharmaceutical bulletin, 2000, vol. 48, no. 7, p. 991-993.
- Abe, F., Yamauchi, T. Pregnane glycosides from the roots of Asclepias tuberosa. Chemical & pharmaceutical bulletin, 2000, vol. 48, no. 7, p. 1017-1022.
- Warashina, Tsutomu., Umehara, Kaoru., Miyase, Toshio., Noro, Tadataka. 8,12;8,20-Diepoxy-8,14-secopregnane glycosides from roots of Asclepias tuberosa and their effect on proliferation of human skin fibroblasts . Phytochemistry, 2011, vol. 72, no. 14-15, p. 1865-1875. DOI
- Warashina, Tsutomu., Noro, Tadataka. 8,14-Secopregnane glycosides from the aerial parts of Asclepias tuberosa. Phytochemistry, 2009, vol. 70, no. 10, p. 1294-1304. DOI
Boundary
A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.
Continue
Europe PMC
Every record indexed for this species, resolvable and re-runnable.
All speciesSubstance index
Search and browse every species this world holds under source and hash.
Before anything elseSafety Centre
Interactions, contraindications and the escalation boundary this world does not cross.
In its own termsTraditions
How the living traditions approach preparation, use and context.